Egyptian Dermatology Online Journal, Volume 1 Number 2


Human Skin Cell Culture and its Impact on Dermatology

Mohamed Badawy Abdel-Naser *, Marwa Abdallah *, Hiram Larangeira de Almeida Jr. **, Uwe Wollina ***

Egyptian Dermatology Online Journal 1 (2): 1, December 2005

* Dermatology and Venereology Dept., Ain Shams University, Cairo Egypt.
** Dermatology Dept., Federal and Catholic University, Pelotas, Brazil.
*** Dermatology and Venereology Dept., Hospital Dresden – Friedrichstadt, Dresden, Germany.

Click Here for a Printable PDF version  

Accepted for publication in September 15, 2005.


Initial attempts to grow skin and its cellular components centered on the use of organ cultures and explants cultures, where whole pieces of skin were kept alive and growth was confined to the epipole around the piece or onto the plastic around the explants. These cultures have a short life span and limited applications, as mixed cultures of keratinocytes, melanocytes, Langerhans cells, fibroblasts, Merkel’s cells, nerve cells and glandular cells are obtained [1].

To understand the function and dysfunction of this complex structure, it is necessary to study partial aspects in models of manageable size and to reintegrate the results back into context, i.e., establishment of pure cell culture of each cellular component of the skin. During the past three decades selective cultivation of cell components of skin has been achieved and considerably added to our understanding of their biology in health and disease. Furthermore, cultivated cells could be reassembled according to experimental design and indications of their use.

Pure cell culture and reconstructed human skin equivalents as an alternative to animal experimentation offer, not only a way to concede to demands of regulatory authorities, animal welfare organizations, consumers and scientists, but also provide a means to improve and extend our knowledge of biological processes in the skin. Molecular definition of disease at the level of the gene and advances in recombinant DNA technology suggest that many diseases are amenable to correction by genes not bearing the defective elements that result in disease. By the use of cell cultures dermatopharmacology has also been enormously stimulated. In addition, modern molecular genetics has been utilized to distinguish between benign and malignant cells providing a mean of targeting the abnormal mutant gene by very specific and precise therapeutic modality, e.g., gene and antisense therapy [2]. In this regard, tissue culture models are ranging from simple monolayer cultures of one cell type to co-cultures of epithelial and mesenchymal cells and finally to three dimensional skin equivalents-organotypic cultures-that form a highly organized epithelium under the control of co-cultured fibroblasts [3]. In skin equivalents, epidermal keratinocytes grow exposed to air on a matrix of type I collagen in which either primary dermal fibroblasts or heterologous mouse fibroblast lines and possibly other cells are embedded, giving rise to almost normal tissue architecture [4]. Presently, various skin reconstructs are available composed either of the epidermal compartment only or of both the epidermal and dermal compartments. Within each compartment various types of cells can be incorporated, including keratinocytes, melanocytes and Langerhans cells in the epidermal, and fibroblasts and endothelial cells in the dermal compartment. The quality of the human skin equivalents has reached a point that their suitability for skin toxicity testing will make great progress. Next to the field of toxicity and safety standards, skin equivalents offer a well-characterized model for studies of the basic skin biology, wound repair, regulation of melanogenesis, pathogenesis of skin diseases and skin cancer [5].

Melanocyte Culture

Melanocytes are highly differentiated neural crest derived cells responsible for synthesizing melanin which is transferred in the melanosomes through dendritic processes to surrounding epidermal keratinocytes. The problem of overgrowth of other epidermal and dermal cells, such as keratinocytes and fibroblasts in culture has been solved and in the past few decades, selective cultivation of human melanocytes from newborn and adult skin has been achieved [6].

Tetradecanoyl phorbol acetate (TPA), cholera toxin and serum containing Dulbecco’s minimal essential medium (DMEM) was the first described melanocyte growth medium. Obtained melanocytes appear slender with a central bulge containing their vesicular nuclei. On both poles, small globular swellings are always observed that represent melanosomes [7]. It has been shown that melanosomes are phagocytosed by surrounding keratinocytes, a process that is controlled by keratinocyte related protease-activated receptor-2 [8]8. Newborn melanocytes usually display two polar dendrites, whereas adult melanocytes frequently have several branched dendrites (Fig. 1) [7].

Because of the presence of serum, melanocytes grown under these conditions are not optimal for examination of factors that may influence melanocyte function as serum may contain substances having functional similarities with those being tested and hence their effects could be masked. Also, the presence of TPA, a potential carcinogenic agent, renders melanocytes grown under these conditions not suitable for therapeutic purposes. Nevertheless, this medium has also several advantages. For example, pure melanocyte cultures are obtained within a few days due to the toxic effects of phorbol esters on keratinocytes. Furthermore, melanocytes can be passaged up to 12-14 passages, enabling reproducibility of the experimental trials, thus posing additional validity to the results obtained in these experiments [7]. In order to circumvent these drawbacks, a serum free and hormone supplemented medium has been successfully used for melanocyte cultivation. The used medium (MCDB 153) supports growth of both keratinocytes and melanocytes, but it is not optimal for growth of fibroblasts. Crude bovine pituitary extract (BPE), cholera toxin, and basic fibroblast growth factor (bFGF) were found essential for melanocyte proliferation. Addition of fetal calf serum (2%) to cultures at time of inoculation and with every passage enhances attachment of the cultivated cells to plates and stimulates their growth. Serum is essential for attachment of adult melanocytes, but not for those of newborn origin, though, melanocyte yield in the absence of serum is low. Keratinocytes and melanocytes grow usually together, however, after 3-4 weeks in adult cultures and 5-7 weeks in newborn cultures the keratinocytes differentiate and separate; whereas, the melanocytes continue to grow and pure melanocyte cultures are obtained (Fig. 2).

Fig. 1: Melanocytes grown in TPA and serum. Cells are slender showing dendrites with terminal swellings Fig. 2: Melanocytes grown in a serum free medium showing fibroblast-like morphology

Newborn melanocytes were found to be bipolar, slender and tended to be less dendritic in comparison with those of adults; both have a fibroblast-like morphology. Moreover, melanocytes obtained from newborn with dark skin showed strong proliferative capacity, were more dendritic and contained more melanin. Newborn melanocytes could be passaged up to 5-6 passages, whereas those of adults up to 3-4 passages only. The identity of the cultured melanocytes is confirmed by being DOPA+, S.100+, HMB 45+ and K.1.2.58+ and by being negative for the other epithelial cell markers, such as CK1, CK10 for keratinocytes and CD1a for Langerhans cells [6, 9].

Melanocytes were almost always seen in contact with the adjacent keratinocyte colonies with dendritic projections and bridged space between colonies. Interestingly, addition of viable keratinocytes to melanocyte cultures showing senescence resulted in restoration of their viability and proliferative activity. It has also been shown that keratinocyte conditioned medium induced melanocyte proliferation and melanization. These observations indicate that keratinocytes synthesize and release factors that modulate melanocyte function. Even in vitro, a close anatomical and functional relationship between melanocytes and keratinocytes exists, thus posing additional validity on the concept of epidermal melanin unit [10]. Cultivation of nevus cells confirmed its melanocytic origin and that the morphologic and behavioral differences observed between epidermal melanocytes and nevus cells in the skin are the result of local environmental influences rather than intrinsic cellular differences [11].

Other factors that have been found to induce melanocyte proliferation are α-MSH, endothelins, leukotrienes, prostaglandins and several others released from adjacent keratinocytes and fibroblasts. In addition, ultraviolet light was found to induce melanocyte melanization and a slight inhibition of melanocyte proliferation. Ultraviolet A (UVA) irradiation did not substantially affect melanocytes whereas ultraviolet B (UVB) irradiation directly activated cultivated melanocytes. On the other hand, IL-1α, IL-6, TNF-α and interferon ß inhibit both melanocyte proliferation and melanin synthesis. These cytokines are released from epidermal and dermal cells in several inflammatory skin conditions and it has been suggested that postinflammatory hypo- and/or hyperpigmentation may result from the effect of these factors on epidermal melanocytes and or epidermal melanin unit. The epidermal melanin unit has now been extended to include not only melanocytes and neighboring keratinocytes, but also Langerhans cells, trafficking lymphocytes and dermal fibroblasts (Table. 1) [12-14].

Table (1): Growth factors and their characteristics [12-14].

Growth factor Site Biologic effect Family
EGF Almost all body fluids, platelets Mitogenic for most epithelial tissues, fibroblasts, endothelial cells. The EGF family includes EGF, TGF-α, VEGF and HBEGF.
TGF-α DC, eosinophils Similar to EGF, but more potent angiogenesis factor
HBEGF DC Mitogenic for keratinocytes.
TGF-β DC, lymphocytes, fibroblasts, keratinocytes, platelets Inhibits replication of most cells in vitro (keratinocytes, endothelial cells, lymphocytes, macrophages) may inhibit or stimulate fibroblasts. TGF-β family (TGF-β1-5) Only TGF-β1-3 are found in mammalian cells and have similar effect.
IGF-1 Most tissues, fibroblasts, DC Mitogenic for fibroblasts, bone cells, neural tissues, haematopoietic cells, endothelial cells. The IGF-1 family (IGF-I and IGF-II). Both have similar structures and effects.
PDGF Endothelial cells, platelets, DC, fibroblasts Mitogenic for vascular smooth muscles, fibroblasts. The PDGF family consists of PDGF and VEGF
VEGF Pituitary cells Mitogenic for endothelial cells but not keratinocytes, smooth muscles or fibroblasts.
FGF (acidic and basic) Fibroblasts, astrocytes, endothelial cells, smooth muscles Mesenchymal and neural tissue mitogen The FGF family (aFGF, bFGF, FGF-5, FGF-6). Only the first 3 have been extensively studied
KGF Fibroblasts Mitogenic for epithelial cells but not fibroblasts or endothelial cells
DC = dendritic cells, EGF= epidermal growth factor, FGF= fibroblast growth factor, HBEGF= heparin-binding EGF, IGF= insulin growth factor, KGF= keratinocyte growth factor, PDGF= platelet-derived growth factor, TGF= transforming growth factor, VEGF= vascular endothelial growth factor.

By the year 2004, melanogenic paracrine and autocrine networks have been elucidated between melanocytes and other types of skin cells. These include endothelin (ET)-1, granulocyte macrophage colony stimulating factor (GM-CSF), membrane type stem cell factor (SCF) and growth-related oncogene-α (GROα) for interactions between keratinocytes and melanocytes, and hepatocyte growth factor (HGF) and soluble type SCF for interactions between fibroblasts and melanocytes [15]. These networks are also associated with corresponding receptors expressed on melanocytes, including ET B receptor and the SCF receptor, c-KIT. Consistent with in vitro findings on the melanogenic paracrine or autocrine cytokine networks, it has been found that the up- or down-regulation of such networks is intrinsically involved in vivo in the stimulation of melanocyte functions in several epidermal hyper- or hypo-pigmentary disorders. These are ET- 1/ET B receptor as well as membrane type SCF/c-KIT for ultraviolet B-melanosis, GM-CSF for ultraviolet A-melanosis, ET-1/ET B receptor as well as membrane type SCF for lentigo senilis, GROα for Riehl’s melanosis, sphingosylphosphorylcholine for hyperpigmentation in atopic dermatitis, ET-1 for seborrheic keratosis, soluble type SCF as well as HGF for dermatofibroma and cafe´ -au-lait macules, and c-KIT for vitiligo vulgaris. These unveiled regulatory mechanisms involved in the abnormal increased or decreased levels of lesional melanocyte function provide new insights into therapeutic tools utilizing blockage of responsible cytokine networks [16].

Cultivated melanocytes have also enriched our knowledge about the pathogenesis of several diseases. Sera of active vitiligo patients exerted cytotoxic effect directly and via the classical pathway of complement activation on melanocytes in vitro, a finding that has been refuted by others. Immunofluorescence studies using living cultivated melanocytes as a substrate revealed deposition of immunoglobulins not only on surface of cultivated melanocytes but also on cultivated keratinocytes and fibroblasts. At the same time, an antibody dependent cellular cytotoxicity (ADCC) and specific melanocyte-specific cytotoxic T cells have been detected. This observation further supports the involvement of the immune system in melanocyte damage in vitiligo [16]. On the other hand, sera of alopecia areata failed to exert any cytotoxic effect on cultured melanocytes casting doubt on involvement of these cells in the pathogenesis of alopecia areata [18]. Western blotting analysis using antigens obtained from cultivated melanocytes in both diseases was also inconclusive [16].

The effect of various agents and drugs has also been examined on cultured melanocytes. It has been shown that nitric oxide (NO), released by inflammatory cells and Langerhans cells is toxic to melanocytes which may play a role in disorders associated with loss of pigmentation [19]. Retinoids reduce tyrosinase activity and therefore are used to regulate pigmentation and lighten hyperpigmented skin. All-trans-retinoic acid (tretinoin) enhanced the toxic effect of hydroquinone on melanocytes [20]. Other inhibitors of melanogenesis by competitive inhibition of tyrosinase are arbutin, kojic acid and possibly niacinamide [21]. Ultraviolet light induced melanocyte cytotoxicity but in vivo it results in melanocyte proliferation and melanization which are due to a paracrine effect. Sera obtained from psoralen plus ultraviolet A (PUVA) responding vitiligo patients induced a significant melanocyte and dermal fibroblasts proliferation indicating that this therapy may have a systemic effect [22]. Reconstructed melanocyte bearing skin is currently used in evaluation of sun screening agents [23].

Normal human melanocytes provided the proper control of melanoma cell research. IFN-α inhibited melanoma cell proliferation in vitro and it is currently an established adjuvant therapy for advanced cases of melanoma. In addition, several oncogenes, e.g., B-raf gene, and adhesion molecules, e.g., E- and N-cadherins, are currently evaluated for being potential targets for therapy and prevention of melanoma progression [24].

Because of the absence of serum and tumor promoting factors, the serum free and hormone supplemented medium could be suitable not only for investigative but also for therapeutic purposes, such as transplantation procedures in patients with vitiligo, piebaldism and other depigmentary disorders. Indeed, several trials have been carried out with successful results and melanocyte transplantation has become one of the established lines of treatment of several recalcitrant hypopigmentary and depigmentary disorders. In the transplantation procedure, either pure melanocytes or epidermal sheet- bearing melanocytes could be utilized [25].

Keratinocyte Culture

Keratinocytes have been successfully cultivated in 1975 when Rheinwald and Green reported the ability to grow pure keratinocytes using a serum containing DMEM/Ham’s F12 medium and a feeder layer (irradiated well-defined transfected mouse 3T3 cells). Shortly thereafter the culture cell yield has been improved by the incorporation of keratinocyte mitogens, such as epidermal growth factor (EGF) and cAMP-elevating agent, the cholera toxin [26].

In cultures, keratinocytes attach as single cells or small clusters and then grow at the periphery of the colony whilst stratifying in the center. The cells form intercellular desmosomes and so grow as coherent colonies until confluent stratifying multilayered sheets are obtained. These have poorly formed squames and do not show normal skin morphology, with cells being flattened, attenuated and forming no stratum granulosum or stratum corneum. Membrane coating granules and keratohyaline granules are sparse and the cultures show the same phenotype as regenerating epidermis [27].

Since the fundamental breakthrough of keratinocyte culture, other ways trying to avoid serum and mouse transfected feeder layer (3T3 cells) in growing keratinocytes have been developed. The search for a defined serum-free medium has resulted in a low–calcium MCDB 153 medium containing several growth factors, which is now commercially available. In low calcium medium (<0.06 mM), the cells fail to form desmosomal interconnections and are spaced out as monolayer (Fig. 3). Although the keratinocytes fail to stratify, they commence terminal differentiation with the expression of involucrin in the larger cells which move suprabasally when calcium levels are restored (to 1.2 mM) (Fig. 4) [28]. The cell cycle is around 22 h with a growth fraction of 60-70%. These systems are therefore heavily weighted towards hyperproliferation [29]. In low Ca++ medium keratinocytes expressed cytokeratins of germinative basal epidermis, namely CK 5 and 14, whereas in high Ca++ medium they expressed cytokeratins of differentiated epidermis, namely CK 1 and 10. BPE was an essential mitogen for keratinocyte proliferation and cells obtained from old individuals showed weak proliferative capacity that hampered their use in autografting [30]. In contrast to epidermal keratinocytes, those obtained from the outer root sheath of hair follicles have extensive proliferative capacity irrespective of donor age, which probably depends on the residing pluripotent epithelial stem cells. Interestingly, autologous outer root sheath keratinocytes are successfully used in grafting of recalcitrant chronic leg ulcers. The use of autologous keratinocytes for grafting depends on mechanical stability of the graft that can be improved in hybrid models. Hyaluronic acid membranes, also known as keratinocyte delivery system, have been proved to be extremely helpful and textile spacers are under investigation for scaffolding cultivated skin structures with plasticity and ease of degradability [31].

Fig. 3: Keratinocytes grown under low Ca++ level. Cells appear as polygonal and monolayer with prominent nuclei. Fig. 4: Keratinocytes grown under high Ca++ level. Cells stratify and show evidence of differentiation.

In skin equivalents, keratinocytes tend to form a more differentiated epidermis, with stratum corneum and granulosum including keratohyaline and membrane coating granules. Although these complex cultures are useful for pharmacological experiments, they provide little tissue expansion, whereas in monocellular cultures one cm of skin can generate 1 m culture area within 6 weeks. This huge population expansion has permitted the use of keratinocyte cultures for skin grafting and keratinocyte grafting. This has been applied to burns, difficult to heal chronic leg ulcers, excision sites of giant melanocytic nevi and correction of hypospadia [32-34]. Both autologous keratinocytes and allogenic keratinocytes have been used, i.e., keratinocytes autografting and keratinocyte allografting. Although allografts do not survive transplantation, they provide a biological dressing and produce wound healing via various cytokine releases [35]. Melanocyte-containing epidermal grafts are an established method for surgical management of leukodermas, e.g., piebaldism [36].

The development of keratinocyte culture has also led to an increased understanding of factors influencing keratinocyte growth and differentiation. Keratinocyte growth factor (KGF) and GM-CSF released by dermal fibroblasts under the effect of IL-1 α and β exert a paracrine effect on keratinocytes and induce their proliferation and differentiation [37]. The keratinocyte has been shown to play an active part in the skin associated lymphoid tissue (SALT) both in cellular interactions with Langerhans cells and epidermotropic T lymphocytes and in the production of several growth factors and cytokines (Table 1). Keratinocytes express Fc γ R and this expression is upregulated by IFN γ [38]. Cytokines produced by keratinocytes include interleukin (IL)-1, -6, -7, -8, -10, -12, -15, -18, and -20 and TNF-α. Keratinocyte-derived IL-7 and -15 are considered to be significant in T-cell trafficking, possibly even in the pathogenesis of cutaneous T-cell lymphoma. IL-15 inhibits keratinocyte apoptosis and plays a role in psoriasis. Immunomodulatory IL-10 and -12 originating from keratinocytes are considered to be responsible for systemic effects, and IL-18 perhaps has a similar action. In addition, IL-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Keratinocytes were fairly recognized as being source or target of other IL-10 family members like IL-20 and IL-24 and the role of these cytokines in specific diseases is under investigation. In addition, a variety of cytokine receptors are present on keratinocytes like those for IL-4, -13, and -17 and to lesser degree IL-2. [39]. NO is produced in high quantities by epidermal keratinocytes in psoriatic skin in response to IFN- γ and TNF- α. Based on these observations several biological agents are introduced in the management of inflammatory skin conditions. Etanercept (Enbrel), infliximab (Remicade) and adalimumab (Humira) as TNF-α antagonists and anaknira (Kineret) as IL-1 blocker have been recently approved for management of severe psoriasis, psoriatic arthropathy and several other inflammatory diseases [40].

Keratinocytes can be transformed by virus exposure, e.g., Simian virus 40 (SV40), human papilloma virus and by oncogene transfections, which have illuminated the process of skin carcinogenesis and antisense therapy to knock out the mutant genes that are responsible for malignancy and metastases. Keratinocytes have been transfected with human growth hormone genes and have been shown to release human growth hormone; a procedure that can be used in delivery of gene products by genetically manipulated grafts [41]. In this regard, this might form a basis for the use of keratinocytes in gene therapy, perhaps to correct genetic defects such as type VII collagen abnormalities in recessive dystrophic epidermolysis bullosa. There is also a growing interest in genetic manipulations ex vivo of epidermal keratinocytes as a curative therapy for otherwise untreatable hereditary dermatoses, such as mechanobullous disorders and xeroderma pigmentosum [42]). Cultivated keratinocytes have also been used to precisely localize and define antigens targeted by various autoantibodies of autoimmune bullous disorders by immunofluorescence, immunoelectronmicroscopy and immunoblotting [43]. Nicotine induced keratinization and cornification of cultured keratinocytes, thus explaining leukokeratosis nicotinica palati [44]). Human leukocyte elastase induces keratinocyte proliferation in vitro, a finding that may explain keratinocyte hyperproliferation in psoriasis [45]).

In keratinocytes, retinoids induce proliferation, resulting in epidermal hyperplasia and modulate epidermal differentiation [46]. Antineoplastic compounds exerted growth inhibitory effect on malignant keratinocytes in vitro. For example, perifosine, a novel alkylphospholipid, induces p21 (WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest [47]). PUVA treatment of keratinocytes reduced ICAM-1 and HLA-DR expression induced by IFN γ and IL- α [48]. Vitamin D3 and its analogues inhibited keratinocyte proliferation, which explains the efficacy of these compounds in treatment of hyperproliferative skin disorders, such as psoriasis [49].

It is now realized that the keratinocyte is not simply a passive cell awaiting terminal differentiation but is an active secretory cell with important biochemical and immune functions.

Sebaceous Gland Cell (Sebocyte) Culture

Selective cultivation of normal human sebaceous gland cells (sebocytes) has helped in investigating disorders of the pilosebaceous units and served as a model for better understanding of drug pharmacokinetics, such as retinoids, androgens and toxic agents with special affinity to lipids [50].

Sebocytes are specialized epithelial cells committed to synthesize lipid rich sebum. Most of the available data of the physiology and pathophysiology of the sebaceous gland originates from hamsters [51]. However, several years ago in vitro cultivation of pure adult human sebocytes has been achieved and well characterized in MCDB 153 medium enriched with serum, cholera toxin, crude BPE, bFGF, hydrocortisone and insulin. Cells grew from the periphery of the lobules to form a single layer sheet of polygonal cells resembling basal keratinocytes (Fig. 5) that later undergo differentiation with increase in cell volume, accumulation of lipids and finally nuclear degeneration and cell death (Fig. 6). Sebocytes in vitro show similar features to keratinocytes being polygonal in shape and synthesize cytokeratins, nevertheless they express specific epidermal membrane antigen that has been used immunohistochemically in their identification [52]. Analytical thin-layer chromatography revealed that the cells synthesized a large amount of sebum-specific lipids, squalene and wax esters in vitro. As the lobules are obtained from adults, sebocyte yield is usually low despite the several methods described for sebocyte cultivation [53]. A modified technique moderately improved the sebocyte yield, but obviously the problem of the donor age and the necessity of serum supplementation were unavoidable obstacles. To overcome the yield problem, sebocytes were transfected by SV 40 large T antigen and the immortalized sebaceous gland cell line SZ95 has been obtained that has been shown to preserve the major functional and behavioral characteristics of normal human sebocytes [54].


Fig. 5: Sebocytes in culture in the proliferative phase showing features of basal keratinocytes. 

Fig. 6: Sebocytes in culture showing evidence of differentiation with refractile lipid vacuoles

It has also been shown that growth hormone stimulates differentiation of sebocytes. Insulin-like growth hormone (IGF-1) increases DNA synthesis and cell proliferation that may contribute to the increase in sebum production during puberty and in acromegaly [55]. Substance P, which can be elicited by stress, promotes the development of cytoplasmic organelles in sebaceous cells, stimulates sebaceous germinative cells and increases the size of individual sebaceous cells and the number of sebum vacuoles for each differentiated sebaceous cell. Therefore, it seems that substance P promotes both the proliferation and the differentiation of sebaceous glands. It has been suggested that this may be responsible for the stress-induced exacerbation of acne [56]. The powerful sebosuppressive effect of some retinoids, such as 13-cis-retinoic acid (isotretinoin), demonstrates that sebocyte differentiation is altered by retinoids. Retinoids inhibit proliferation and lipid synthesis in cultured human sebocytes and alter their keratin expression [57]. Later it has been shown that in addition, 13-cis-retinoic acid (isotretinoin), 3, 4-didehydroretinoic acid, and 3, 4-didehydroretinol, but not all-trans-retinoic acid (tretinoin) or the synthetic retinoids acitretin and adapalene, were potent competitive inhibitors of the oxidative 3 α –HSD activity of RoDH-4. As a result, they reduce the formation of dihydrotestosterone and androstandione in vitro that might explain the unique sebosuppressive effect of isotretinoin when treating acne [58]. Both testosterone and 5 α-dihydrotestosterone significantly stimulated the proliferation of the sebocytes, a finding that has been completely abolished by spironolactone. Cultured sebocytes strongly expressed type 1 5 α-reductase and metabolized testosterone to androstenedione, 5 α-androstanedione, 5 α-dihydrotestosterone, androsterone and 5 α-androstanediol. Stimulation of sebocyte proliferation by insulin, thyroid-stimulating hormone and hydrocortisone indicates that the hormonal control of the sebaceous gland could be a complex mechanism [53, 59]. Incorporation of sebocytes and/or sebaceous glands in skin reconstructs has not been achieved yet.

Langerhans Cell Culture

Langerhans cells (LCs) are dendritic cells present in the epidermis, bronchi and mucosae and are responsible for antigen presentation. The essential role of LC in the induction of contact allergic skin reactions and skin transplant rejection is well established. They have also been cultivated in vitro; however, they usually do not survive more than few weeks as they are considered nearly end differentiated cells and they are few in number. Furthermore, properties of LC, such as phenotype, morphology and the stimulatory potential to activate T lymphocytes, are dependent on the local microenvironment in which the LCs reside, thus correlation between in vitro and in vivo findings is expectedly irrelevant. The initial use of culture medium containing serum resulted in undue LCs activation by serum antigens that further invalidated in vitro findings [60].

Nevertheless, in vitro generation of dendritic cells (DCs) with the typical molecular, morphological and functional features of LC from purified CD34+ progenitor cells of peripheral blood under defined serum-free culture conditions has been achieved. TGF- β 1 was found to be an absolute requirement for in vitro LC development under serum-free conditions upon stimulation with the classical DC growth and differentiation factors GM-CSF, TNF-α and SCF (Table 1). The recently identified cytokine FLT3 ligand further dramatically enhanced in vitro LC development and even allowed efficient in vitro generation of LC colonies from serum-free single cell cultures of CD34+ hemopoietic progenitor cells (Fig. 7, 8) [61].

Fig. 7: Langerhans cells cultivated in the absence of serum.

Fig. 8: Langerhans cells grown in presence of serum showing higher number of dendritic cells.

The procedure of LC cultivation was further refined by isolation of immature epidermal LC in sufficient numbers mechanically by three-step Ficoll floatation, a method that was found to be superior to the well-known positive immuno-magnetic separation by anti-CD1a-coated beads. This has enabled easy isolation of LCs not only from peripheral blood but also from the epidermis and mucosa. The medium used is RPMI supplemented with HEPES, L-glutamine, non-essential amino acids and sodium pyruvate. Both epidermal and circulating LC appear rounded cells but with multiple small dendrites [62].

Not only epidermal but also mucosal LCs have been cultivated in vitro and it has been shown that LCs in human oral epithelium are more efficient at stimulating T cells than those of skin which may be of value as both cells meet different antigenic challenges [63]. LCs could be successfully kept viable after cryopreservation and it has been shown that cryopreserved LCs expressed high levels of HLA-DR and CD1a antigens and stimulated autologous T cells to an extent almost identical to that obtained from fresh LCs. These findings indicate that the cryopreservation of human LCs could lead to a breakthrough in various experiments dealing with these cells [64].

In atopy, Fc epsilon RI-activated LCs release chemotactic signals and increase the migratory capacity of naive T cells in vitro. Furthermore, they produce high amounts of proinflammatory cytokines and chemokines, prime naive T cells into IFN- γ -producing T cells and release IL-12 and IL-18, which together might lead to the switch of the initial T (H) 2-type immune response into a response of the T (H) 1 type in vivo [65]. The role of LCs in contact dermatitis has also been tested in vitro and it has been found that contact sensitizers, such as dinitrochlorobenze, caused an increase of the co-stimulatory molecule CD86, of intercellular adhesion molecule CD54 and of the HLA-DR antigen, whereas the irritant sodium dodecyl sulphate and the vehicle dimethyl sulfoxide had no effect on LCs [66].

Recently, LCs have been used to test a variety of immunomodulating agents in vitro. The topical immunomodulators tacrolimus and pimecrolimus and steroid ointment induced a selective depletion of inflammatory dendritic cells in the epidermis of atopic dermatitis patients and reduced the expression of the co-stimulatory molecules CD80 and CD86 in vivo. However, tacrolimus did not increase the rate of apoptotic LCs whereas steroid did so in vitro [67]. Assessment of cellular parameters related to UV-induced immunosuppression and the effect of sun screening agents is performed using the reconstructed epidermis containing LCs. Exposure to solar-simulated radiation provokes morphological alterations, reduces surface antigen expression and reduces the numbers of LCs cells within the exposed epidermis [68].

At the present time there is a growing interest in the use of cultivated LCs in the management of allergic contact dermatitis and malignancy. Following activation by haptens, LCs migrate to regional lymph nodes to activate effector T cells. This step can be prevented in manipulated epidermal LC by inhibitory peptide, 1 an apoptotic gene that binds and blocks the function of hyaluronic acid (hyaluronan), which is known to serve as an adhesive substrate for LC migration. Furthermore, creating a "killer" LC clone by introduction of CD95L cDNA, either before or after sensitization, results in marked suppression of contact hypersensitivity by only eliminating the pathogenic T cells [69]. The mitogenic effect of TNF-α and GM-CSF on LCs in vitro has encouraged physicians to use them systemically as an adjuvant therapy to tumor vaccination [70]. Anti-melanoma immunization therapy is currently tried in patients, through dendritic cells charged with melanoma antigens with, so far, limited side effects. Injections of antigenically charged dendritic cells were performed subcutaneously, intravenously or in the lymph nodes. Interestingly, positive clinical responses were obtained with complete remission of the metastasis in some cases [71].

Dermal Fibroblast Culture

Fibroblasts are the most numerous cells found in the loose connective tissue and they are responsible for the manufacture of all its elements or their precursors. Fibroblasts are the easiest cells to cultivate in vitro, as their growth requirements are minimal in comparison to other human cell types. Indeed, their isolation and propagation have helped not only in understanding the biology of these cells but also the biology of other cells by serving as control cells for almost all investigative work done so far. They have also been used extensively in pharmacological tests and skin reconstruction. Fibroblasts are grown in DEMEM medium supplemented with L glutamine and 10% fetal calf serum. They can also be adapted to grow in serum free medium. When cultured in monolayer, dermal fibroblasts have an elongated spindle shape with a prominent nucleus, are small in diameter and grow at a high rate (Fig. 9) [72].

Fibroblasts obtained from newborn generally have greater mitogenic responsiveness than adult fibroblasts and that age-associated loss of growth factor responsiveness may contribute to the decreased proliferative capacity of old-donor cells. It has been shown that dermal fibroblasts possess a finite replicative capacity of 50 to 100 doublings, and then cease replication in response to growth factors. Cells cultivated to the end of their replicative life span in vitro overexpress metalloproteinase activities that may explain the age-related progressive destruction of the collagenous and elastic components of the extracellular matrix [73]. In contrast to dermal fibroblasts, wound fibroblasts grew slowly and were large, star shaped and had cytoplasmic stress fibres. Smooth muscle α actin was detected in the cytoplasm of most wound fibroblasts. Wound fibroblasts also contract collagen gels during the first days more strongly than dermal fibroblasts. These results show that, in vitro, wound fibroblasts have greater contractile capacity than dermal cells. The significant proportion of wound fibroblasts containing α-smooth muscle actin suggests that α-smooth muscle actin ratio may be related to wound contraction [74].

Fig. 9: Fibroblasts in culture appear as spindle shaped cells with indistinct cell boundaries.

Fig.10: Endothelial cells in culture are similar to fibroblasts but with distinct cellular boundaries

Dermal fibroblasts are the source of collagen and elastin of the extracellular matrix (ECM). Procollagens are secreted through the Golgi apparatus in the extracellular space where the N-terminal and C-terminal propeptides are cleaved by specific proteases. The mature processed collagen molecules aggregate to form larger collagen fibrils and help to form the ECM with other components. Therefore, normal structural and functional type I collagen production and deposition to make normal physiological connective tissue needs regulation at several steps. Abnormality in any step may cause hypo-, hyper-, or defective synthesis and accumulation of collagen in ECM, which in turn causes different diseases in humans, such as osteogenesis imperfecta, scurvy, scleroderma or systemic sclerosis, keloids, and others [75]. Elevated level of type I collagen in scleroderma skin fibroblasts is primarily due to the increased rate of collagen gene transcription. Increasing evidence suggests that TGF- β plays a significant role in fibrosis [76]. Dermal fibroblasts are also an important source of several cytokines, e.g., IL -1 and 6, chemokines, e.g., cyclooxygenase 2 (COX-2) and growth factors, e.g., FGF, IGF-1 α that have significant autocrine and paracrine effects (Table 1)[77]. Interferons α, β and γ suppress collagen synthesis by dermal fibroblasts. In particular, IFN- γ inhibits the constitutively increased collagen synthesis characteristic of fibroblasts derived from lesions of patients with scleroderma. Inhibition of collagen synthesis by IFN- γ is associated with a coordinate inhibition of transcription for types I and III collagen. Animal studies demonstrated that IFN- γ inhibits the collagen synthesis associated with the fibrotic response to an implanted foreign body, bleomycin-induced pulmonary fibrosis, and the healing response to cutaneous thermal burns. Interferon α can decrease the size of keloids of recent onset [78].

Hyaluronan is a ubiquitous extracellular matrix component, and is present at high concentrations in skin, joints and cornea. In the skin, it is synthesized primarily by dermal fibroblasts and to a lesser extent by epidermal keratinocytes. It is commonly used in cosmetics and skin care preparations [79].

Dermal fibroblasts play also a significant role in inflammation. They, besides neutrophils and macrophages, can elaborate the proinflammatory matrix metalloproteinases 1, 3 and 9 in response to injurious agents, such as immune complexes, lipopolysaccharides and UVB radiation both directly and indirectly by IL-1 α and 6 released by keratinocytes [80]. Dermal fibroblasts may contribute to the epidermal hyperplasia of psoriasis by promoting keratinocyte proliferation through IGF-1, the secretion of which could be modulated by inflammatory cytokines, such as IFN-α (Table. 1) [81].

Several drugs have been tested with dermal fibroblasts. In vitro exposure of fibroblasts to 8-methoxypsoralen and UVA resulted in growth inhibition with morphological and functional changes reminiscent of replicative senescence that also occur in vivo upon exposure to sublethal stressors, i.e., hyperoxia, hydrogen peroxide, and ethanol [82]. Heparin inhibits dermal fibroblast proliferation and collagen production but significantly stimulates bFGF and TGF β 1 by normal, fetal and keloid fibroblasts which may play a role in wound healing [83]. Although minocyclin has been used to treat fibrosis, it did not alter dermal fibroblast proliferation or collagen synthesis [84]. Retinoids stimulate dermal fibroblasts to produce extracellular matrix proteins, particularly when the skin is damaged by wounding, ultraviolet radiation or glucocorticoids [85]. Inhibition of dermal activity by cortisol in culture was partially reversed by testosterone and dihydrotestosterone, whereas ACTH and the androgen precursor dehydroepiandrosterone sulphate did not show such antagonistic effect. These results suggest that increased production of adrenal androgens during ACTH therapy may account for the relative absence of 'skin-thinning' and 'steroid-bruising' which are common side-effects of corticosteroid therapy [86]. On the other hand, triamcinolone acetonide has been shown to decrease both cellular proliferation and collagen production by dermal fibroblasts and increases the production of bFGF and decreases production of TGF- β 1 by human dermal fibroblasts [87]. Glycolic acid (GA), commonly used in chemical peeling and skin rejuvenation, increases collagen synthesis by fibroblasts and modulates matrix degradation and collagen synthesis through keratinocyte-released IL-1 α. These results suggest that GA contributes to the recovery of photodamaged skin through various actions, depending on the skin cell type [88].

Besides the use of dermal fibroblasts in almost all skin substitutes, there are currently trials attempting at transplanting genetically modified fibroblasts carrying a stably integrated tarnsgenes as a vehicle for normal genes [89].

Dermal Endothelial Cell Culture

Dermal endothelial cells involved in tumor angiogenesis, wound healing, and inflammation are predominantly of micro vascular origin and are functionally distinct from large vessel-derived endothelial cells which have been largely used for in vitro vascular research. Initially, cultivation of dermal endothelial cells has been achieved using high concentrations of serum and conditioned media from tumors to achieve optimal growth [90]. Contamination of the cultures with other cell types, such as fibroblasts was evident, however, with some modifications of the culture procedure in which continuous Percoll gradient was applied; pure endothelial cells could be obtained. The culture medium consisted of endothelial cell basal medium supplemented with EGF and hydrocortisone [91]. The cultivation of endothelial cells in vitro was later facilitated by the incorporation of the potent mitogen vascular endothelial growth factor (VEGF) that also functions as a survival factor for endothelial cells by up-regulating Bcl-2 expression (Fig. 10) [92]. Several cellular components of the skin synthesize and release VEGF in vivo and in vitro (Table 1).

Clearly, the growth and turnover of endothelial cells in the skin is fundamental not only in normal development, but also in wound repair, hair follicle cycling, tumor cell metastasis, and in many different states of cutaneous pathology. Endothelial cells in vitro acquire a slightly elongated epithelioid (cobblestone) shape in the modified and now commercially available endothelial cell growth medium MV and are labeled with Ulex europaeus Agglutinin I and an antibody against Factor VIII-related antigen [93]. To further overcome the problems commonly involved in the culture of microvascular endothelial cells, including unreliable isolation techniques and low cell yields, a simplified protocol for the selective isolation and cultivation of human dermal microvascular endothelial cells from neonatal foreskins has been proposed. It utilizes immunomagnetic beads and it is based on the transient, endothelial cell-specific induction of E-selectin by TNF-α [94].

The effects of several cytokines have been examined on cultivated dermal endothelial cells in vitro. GM-CSF and IL–1 α and β induced endothelial cell proliferation, whereas IFN– γ and TNF α activated them by induction of HLA-DR and ICAM-1 expression [91]. Activated endothelial cells also help in initiating immune reactions as antigen presenting cells as they express adhesion molecules such as E selectin, ICAM- 1 and VCAM-1 that are essential in memory and effector T cell recruitment [95]. In wound healing, a dynamic interaction occurs among endothelial cells, angiogenic cytokines, such as FGF, VEGF, TGF- β, angiopoietin, and mast cell tryptase, and the extracellular matrix environment [96]. Fibrin fragment E liberated at wounds stimulates the proliferation, migration and differentiation of human dermal microvascular endothelial cells in vitro, both in the absence and presence of additional endothelial growth factors, such as VEGF and bFGF indicating a possible synergy between the signaling pathways used by these three angiogenic factors [97]. Increase of Bcl 2 on endothelial cells is associated with intratumoral angiogenesis enhancement and accelerated tumor growth [98]. On the other hand, several agents inhibited endothelial cell proliferation and angiogenesis. Angiotensin type II (AT2) receptor stimulation is antiangiogenic through inhibition of VEGF-induced endothelial cell migration and tube formation via activation of a PTX-sensitive G protein [99].

Kaposi's sarcoma-associated herpes virus (KSHV) is consistently found in all forms of Kaposi’s sarcoma. Infection of dermal microvascular endothelial cells with KSHV induces spindle cell formation in vitro by a c-kit dependent mechanism. Endothelial cells are used as host cells for culturing and propagation of this virus [100]. Similarly, Bartonellosis, a disease caused by motile intracellular bacteria, produces characteristic dermal eruption that results from a pronounced endothelial cell proliferation (Verruga peruana). Also an extract of Bartonella bacilliformis organisms induced endothelial cell proliferation in vitro [101].

The effect of physical agents and drugs has also been studied on endothelial cells in vitro. Hypoxia resulted in synthesis and release of VEGF by endothelial cells and possibly by pericytes which contributes to their proliferation and subsequent angiogenesis, i.e., autocrine effect [102]. Ultraviolet radiation induces nitric oxide synthase 2 expression by endothelial cells which may provide an explanation of the erythema, edema and inflammation [103]. On the other hand, hypertension in end stage renal failure has been attributed to uremic plasma factors inhibiting nitric oxide synthase 2 with subsequent lack of vasodilatation and persistent vasoconstriction [104]. Tumors promote angiogenesis by secreting growth factors, such as VEGF and VEGF-related molecules either spontaneously or in response to hypoxia that stimulates endothelial migration, proliferation, proteolytic activity, and capillary morphogenesis. Newly formed blood vessels supply the tumor with nutrients and oxygen, dispose of its metabolic waste products, and generate paracrine stimuli, which further promote tumor cell proliferation and invasiveness [105]. Endostatin exerts it powerful antiangiogenic effect through inhibition of endothelial cell proliferation by E selectin dependent mechanism [106].

Griseofulvin has been used as an antifungal drug for many years, but it has recently been shown to be effective in several inflammatory skin diseases. Griseofulvin inhibited the expression of TNF α-induced VCAM-1 dose-dependently, and this inhibition was fully reversible. Similarly, griseofulvin inhibited the induction of VCAM-1 expression on both TNF α- and IL-1 α-stimulated human endothelial cells indicating potent immunomodulatory properties, which may be associated with its feature as a microtubule antagonist [107]. Retinoids inhibit whereas steroids induce proliferation of endothelial cells without effecting HLA-DR, ICAM-1 induction by IFN γ, TNF α and IL-1 α [108]. Nevertheless, retinoids inhibited VCAM-1 gene expression and VCAM-1 T cell binding to cytokine-treated endothelial cells thus explaining their anti-inflammatory effect [109].

Successful reconstruction of human skin model containing keratinocytes, fibroblasts and endothelial cells has been described. The therapeutic implications of this culture have yet not been verified [101].

Hair Follicle Cell Cultures

Different culture models are used to investigate hair biology. With organ cultures the whole hair follicle is maintained in the culture in order to investigate the effect of different substances on hair growth. The development of medications to stimulate or to inhibit the production of hair keratine may have great impact on the treatment of baldness and hypertrichosis, respectively [111].

Regarding selective cell culture models, two different compartments of the hair follicle are the main objective of research, namely hair keratinocytes from the outer root sheath (ORS) and mesenchymal cells of dermal papilla (DPC).

ORS keratinocytes can be easily obtained from plucked hairs, using the trichogramm technique [112], thus avoiding any surgical procedure to isolate the ORS keratinocytes. Culture medium and mitogens are almost the same that are used in selective cultivation of epidermal keratnocytes. With this culture model the outgrowth of keratinocytes from the ORS is seen as early as two days following inoculation (Fig. 11); they produce multilayered cell colonies, in which desmosomes could be identified [112]. Alltough they do not produce the hair keratin, these cells can be used to study hair biology and indeed the inhibition of androgens on ORS keratinocytes proliferation has already been shown [113]. Vellus hair follicle cells were also successfully cultivated [114].

Figure 11: Outgrowth of keratinocytes from the outer root sheath.

Figure 12:Typical aggregative growth pattern of dermal papilla cells

As a source of keratinocytes and similar to epidermal cultures, ORS cells can also be used to treat recurrent leg ulcers [115]. Future models in this field may elucidate important aspects of hair graying and even may have therapeutic implications, since melanocytes of graying and white hair follicles can be induced to produce melanin in vitro [116].

DPC have a close contact to the keratin-producing hair matrix cells, being very important to study epithelial-mesenchymal interactions in the hair follicle. Complex culture-models have been developed [117]. They can be dissected from the hair follicle and grow in medium identical to that of dermal fibroblasts [118]. They have gained much interest due to their ability to induce hair growth after reimplantation in the skin [119,120].

When DPC were compared to dermal fibroblasts, many differences were found. They express muscle antigens [121], have a weaker capacity to contract collagen lattices and have an aggregative growth pattern [122] (Figure 12). Recently a difference in expression and activation of matrix metalloproteinases was also shown [123], reinforcing the concept that they are a specialized subpopulation of mesenchymal cells.

As a target of androgen effect in the hair follicle [113],124] , DPC were used to investigate androgenetic alopecia [125]. Well stablished treatments for this condition were confirmed in vitro using DPC. Minoxidil has a proliferative and anti-apoptotic effect [126] and finasteride increases the expression of growth factors on DPC in vitro [127]

Other Cutaneous Cell Cultures

Other cutaneous cells of less importance have also been cultivated in vitro. Merkel cell is a highly specialized cell of neural crest origin that primarily acts as slowly adapting mechanoreceptors. Their in vitro cultivation and characterization has been hampered by their paucity, lack of information about specific mitogens and their state of differentiation. Nevertheless, they have recently been cultivated from animals and humans from both glabrous and hairy skin [128]. Merkel cells of sinus hair follicles of rats have been grown as a monolayer that exhibited flat round morphology with extended lamellae on their fringes in serum free medium, whereas they acquire a fibroblast-like morphology and survive longer in the presence of serum [129]. Establishment of a cell line from Merkel cell carcinoma in humans was possible. In general, cells grow as loosely arranged floating small aggregates on RPMI medium on irradiated fibroblast feeder layer. They also retain their in vivo properties, namely expression of cytokeratin 18, neuron-specific enolase, neurofilaments and synaptophysin. The expression of the distinct cytokeratin 20 has greatly facilitated their identification in vitro and in vivo and also improved detection of micro metastasis of Merkel cell carcinoma [130].

Epithelial cells were also cultivated from the secretory coil and collecting ducts of the sweat glands in a medium supplemented with fetal calf serum, insulin, transferring, epidermal growth factor and hydrocortisone. Initially, cells of the secretory coil were elongated while of the collecting ducts were polyhedral [131]. Fibroblast overgrowth was markedly diminished by dispase separation and use of serum free medium similar to keratinocytes. Cells expressed carcinoembryonic antigen, K 8.37 and K 8.13 [132]. Ultrastructural studies revealed domes indicative of transepithelial active ion transport in cells of reabsorptive duct [131]. Sweat gland myoepithelial cells in culture expressed, in addition to unique cytokeratins, α smooth muscle actin (sma) [133]. Cells isolated from patients with cystic fibrosis were morphologically indistinguishable from normal except for high transepithelial resistance and increased amiloride sensitivity, i.e., functionally abnormal [134]. Skin equivalent studies revealed that keratinocytes of young donor could differentiate toward sweat ducts in vitro in the presence of serum, EGF and dermal fibroblasts [135]135).



1. Cruickshank CN, Cooper JR, Hooper C. The cultivation of cells from adult epidermis. J Invest Dermatol 1960, 34:339-342.

2. Jansen B, Zangemeister-Wittke U. Antisense therapy for cancer-the time of truth. Lancet Oncol 2002; 3:672-683.

3. Fusenig NE. Epithelial-mesenchymal interactions regulate keratinocyte growth and differentiation in vitro. In: The Keratinocyte Handbook (Leigh, I. et al., eds). Cambridge University Press. 1994, pp 71-94.

4. Stark H-J. Bauer M, Breitkreutz D, Mirancea N, Fusenig NE. Organotypic keratinocyte coculture in defined medium with regular epidermal morphogenesis and differentiation. J Invest Dermatol 1999, 112, 681-691.

5. Stark H-J. Szabowski A, Fusenig NE, Maas-Szabowski N.Organotypic co-cultures as skin equivalents: A complex and sophisticated in vitro system. Biol Proced Online 2004, 6:55-60.

Melanocyte Culture

6. Gilchrest BA, Vrabel MA, Flynn E, Szabo G. Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol 1984; 83:370-376.

7. Eisinger M, Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 1982, 79:2018-2022.

8. Seiberg M. Keratinocyte-melanocyte interactions during melanosome transfer. Pigment Cell Res 2001; 14:236-242.

9. Abdel-Naser MB: Mitogen requirements of normal human melanocytes in a serum and tumor promoter free medium. Eur J Dematol 2003: 13:29-33.

10. Abdel-Naser MB: Differential effects on melanocyte growth and melanization of low vs high Ca++ keratinocyteconditioned medium. Brit J Dermatol 1999; 140:50-55.

11. Gilchrest BA, Treloar V, Grassi AM, Yaar M, Szabo G, Flynn E. Characteristics of adult human nevocellular nevus cells. J Invest Dermatol 1986; 87:102-106.

12. Tada A, Periera E, Beitner-Jihnson D, Kavaungh R, Abdel-Malek ZA. Mitogen and ultraviolet B-induced signaling pathways in normal human melanocytes. J Invest Dermatol 2002; 118:316-322.

13. Abdel-Naser MB, Krasagakis K, Garbe C, Eberle J. Direct effects on proliferation, antigen expression and melanin synthesis of cultured normal human melanocytes in response to UVB and UVA light. Photodermatol Photoimmunol Photomed 2003; 19:122-127.

14. Cross KJ, Mustoe TA. Growth factors in wound healing. Surg Clin North Am 2003; 83:531-545.

15. Halaban R. The regulation of normal melanocyte proliferation. Pigment Cell Res 2000; 13:4-14.

16. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004; 17:96-110.

17. Van den Wijngaard R, Wankowicz-Kalinska A, Pals S, Weening J, Das P. Autoimmune melanocyte destruction. Lab Invest 2001; 81:1061-1067.

18. Abdel-Naser MB, Blume U, Abdel-Fattah A, Orfanos CE.Evidence for a complement mediated inhibition and an antibody dependent cellular cytotoxicity of dermal fibroblasts in alopecia areata. Acta Derm Vener (Stockh)1994; 74:351-354.

19. Iuga AO, Qureshi AA, Lerner EA. Nitric oxide is toxic to melanocytes in vitro. Pigment Cell Res. 2004; 17:302-306.

20. Kasraee B, Handjani F, Aslani FS. Enhancement of the depigmenting effect of hydroquinone and 4-hydroxyanisole by all-trans-retinoic acid (tretinoin): the impairment of glutathione-dependent cytoprotection? Dermatology 2003; 206:289-291.

21. Yoon TJ, Lei TC, Yamaguchi Y, Batzer J, Wolber R, Hearing VJ. Reconstituted 3-dimensional human skin of various ethnic origins as an in vitro model for studies of pigmentation. Anal Biochem 2003; 318:260-269.

22. Abdel-Naser MB, Hann SK, Bystryn JC. Oral psoralen with UVA therapy releases circulating growth factor(s) that stimulate cell proliferation. Arch Dermatol 1997; 133:1530-1533.

23. Duval C, Schmidt R, Regnier M, Facy V, Asselineau D, Bernerd F. The use of reconstructed human skin to evaluate UV-induced modifications and sunscreen efficacy. Exp Dermatol 2003; 12:64-70.

24. Perlis C, Herlyn M. Recent advances in melanoma biology.The Oncologist 2004; 9:182-187.

25. Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, Paterna P, Sonego G, Gobello T, Atzori F, Piazza P, Luci A, De Luca M. Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Arch Dermatol 2003; 139:1303-1310.

Keratinocyte Culture

26. Rheinwald JG, Green H. Epidermal growth factor and multiplication of cultured human keratinocytes. Nature 1977; 265:421-424.

27. Holbrook KA, Hemmings H. Phenotypic expression of epidermal cell in vitro; a review. J Invest Dermatol 1983; 81:11-24.

28. Boyce ST, Ham RG. Calcium regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 1983; 81:33-40.

29. Albers KM, Taichmann LB. Kinetics of withdrawal from the cell cycle in cultured human epidermal keratinocytes. J Invest Dermatol 1984; 82:161-164.

30. Abdel-Naser MB, Abdel-Fattah A, Abdallah MA. Selective cultivation of epidermal keratinocytes from newborn and adult skin in a serum free medium and without the use of a feeder layer. Gulf J of Dermatol and Venereol 1998; 5:18-23.

31. Wollina U, Heide M, Mueller-Litz W, Obenauf D, Ash J. Functional textiles in prevention of chronic wounds, wound healing and tissue engineering. Current Problems of Dermatology 2003; 31:82-96.

32. Gallico GG, O’Connor NE, Compton CC, Remensnyder JP, Kehinde O, Green H. cultured epithelial autografts for giant congenital nevi. Plast Reconstr Surg 1989; 84:1-9.

33. De Luca M, Albanese E, Cancedda R, Viacava A, Faggiuni A, Zambruno G, Giannetti A. Treatment of leg ulcers with cryopreserved allogenic cultured epithelium. Arch Dermatol 1992; 128:633-638.

34. Romagnoli G, De Luca M, Faranada F, Bandelloni R, Franzi AT, Cataliotti F, Cancedda R. treatment of posterior hypospadius by autologous graft of cultured urethral epithelium. N Eng J Med 1990; 323:527-530.

35. Ehrlich HP Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds. Am J Surg 2004; 187:29-33.

36. Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, Kuhn S, Piazza P, Luci A, Atzori F, De Luca M. Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis. Br J Dermatol 2004; 150:715-721.

37. Werner S, Smola H. Paracrine regulation of keratinocyte proliferation and differentation. Cell Biol 2001; 11:143-146.

38. Cauza K, Grassauer A, Hinterhuber G, Horvat R, Rappersberger K, Wolff K, Foedinger D. FcgammaRIII expression on cultured human keratinocytes and upregulation by interferon-gamma. J Invest Dermatol 2002; 119:1074-1079.

39. Grone A. Keratinocytes and cytokines.Vet Immunol Immunopathol. 2002; 88:1-12.

40. article/463653. Shaun Ruddy. Cytokine blockers for inflammatory arthritis.

41. Morgan JR, Barrandon Y, Green H, Mulligan RC. Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 1987; 237: 1476-1479.

42. Magnaldo T, Sarasin A. Genetic reversion of inherited skin disorders. Mutat Res. 2002; 509:211-220.

43. Batteux F, Franck N, Jaffray P, Raulo M, Prost C, Leibowitch M, Escande JP, Weill B. An extract from cultured human keratinocytes that contains the major autoantigens related to autoimmune bullous skin diseases. J Clin Immunol 1997; 17:228-233.

44. Groemer FE, Bernd A, Bereiter-Hahn J, Holzmann H. A new model of epidermal differentation: induction by mechanical stimulation. Arch Dermatol Res 1990; 282:22-32.

45. Rogalski C, Meyer-Hoffert U, Proksch E, Wiedow O: Human leukocyte elastase induces keratinocyte proliferation in vitro and in vivo. J Invest Dermatol 2002; 118:49-54.

46. Gendimenico GJ, Mezick JA. Pharmacological effects of retinoids on skin cells. Skin Pharmacol 1993; 6:24-34.

47. Patel V, Lahusen T, Sy T, Sausville EA, Gutkind JS, Senderowicz AM. Perifosine, a novel alkylphospholipid, induces p21 (WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest. Cancer Res 2002; 62:1401-1409.

48. Urano R, Urano K, Matsuyama T, Matsuo I, Ohkido M PUVA treatment of human keratinocytes suppresses the surface expression of intercellular adhesion molecule 1 (ICAM-1) and inhibits adherence of PHA-blasts in vitro. Tokai J Exp Clin Med 1997; 22:71-76.

49. Kobayashi T, Hashimoto K, Yoshikawa K. Growth inhibition of human keratinocytes by a new vitamin D3 analogue in vitro. J Dermatol Sci 1998; 16:158-164.

Sebaceous Gland Cell (Sebocyte) Culture

50. Cunliffe WJ. The sebaceous gland and acne- 40 years on. Dermatology 1998; 196:9-15.

51. Ito A, Sakiguchi T, Kitamura K, Akamatsu H, Horio T. Establishment of a tissue culture system for hamster sebaceous gland cells. Dermatology 1998; 197:238-244.

52. Xia L, Zouboulis Ch, Detmar M, Mayer-de-Silva A, Stadler R, Orfanos CE. Isolation of human sebaceous glands and cultivation of sebaceous gland derived cells as an in vitro model. J Invest Dermatol 1989; 93:315-321.

">53. Fujie T, Shikiji T, Uchida N, Urano Y, Nagae H, Arase S.Culture of cells derived from the human sebaceous gland under serum-free conditions without a biological feeder layer or specific matrices. Arch Dermatol Res 1996; 288:703-708.

54. Zouboulis ChC, Seltmann H, Neitzel H, Orfanos CE. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 1999; 113:1011-1020.

55. Deplewski D. Rosenfield RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999; 140:4089– 4094.

56. Toyoda M, Morohashi M. Pathogenesis of acne. Med Electron Microsc 2001; 34:29-40.

57. Gendimenico GJ, Mezick JA. Pharmacological effects of retinoids on skin cells. Skin Pharmacol 1993; 6:24-34.

58. Karlsson T, Vahlquist A, Kedishvili N, Torma H. 13-cis-retinoic acid competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands? Biochem Biophys Res Commun 2003; 303:273-278.

59. Zouboulis CC, Xia L, Akamatsu H, Seltmann H, Fritsch M, Hornemann S, Ruhl R, Chen W, Nau H, Orfanos CE. The human sebocyte culture model provides new insights into development and management of seborrhea and acne. Dermatology 1998; 196:21-31.

Langerhans Cell Culture

60. Teunissen MB. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells. Histochem J 1992; 24:697-716.

61. Strobl H, Riedl E, Bello-Fernandez C, Knapp W. Epidermal Langerhans cell development and differentiation. Immunobiology. 1998; 198: 588-605.

62. Tchou I, Sabido O, Lambert C, Misery L, Garraud O, Genin C. Technique for obtaining highly enriched, quiescent immature Langerhans cells suitable for ex vivo assays. Immunol Lett 2003; 86: 7-14 .

63. Hasseus B, Jontell M, Bergenholtz G, Dahlgren UI. Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin. Clin Exp Immunol. 2004; 136:483-489.

64. Seo KI, Huh CH, Han JH, Youn JI, Lee CH, Lee WJ, Eun HC. Characterization of cryopreserved human Langerhans cells. Cryobiology. 2002; 45: 118-126.

65. Novak N, Valenta R, Bohle B, Laffer S, Haberstok J, Kraft S, Bieber T. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol. 2004; 113: 949-957

66. Tuschl H, Kovac R. Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. Toxicol In Vitro 2001; 15: 327-331.

67. Schuller E, Oppel T, Bornhovd E, Wetzel S, Wollenberg A. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis. J Allergy Clin Immunol 2004; 114:137-143 .

68. Duval C, Schmidt R, Regnier M, Facy V, Asselineau D, Bernerd F. The use of reconstructed human skin to evaluate UV-induced modifications and sunscreen efficacy. Exp Dermatol 2003; 12: 64-70.

69. Takashima A, Mummert M, Kitajima T, Matsue H. New technologies to prevent and treat contact hypersensitivity responses. Ann N Y Acad Sci 2000; 919: 205-213 .

70. Janik JE, Miller LL, Kopp WC, Taub DD, Dawson H, Stevens D, Kostboth P, Curti BD, Conlon KC, Dunn BK, Donegan SE, Ullrich R, Alvord WG, Gause BL, Longo DL. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients. Clin Immunol 1999; 93:209-221.

71. Schmitt D. The Langerhans cell: from in vitro production to use in cellular immunotherapy. J Soc Biol. 2001; 195:69-74.

Dermal Fibroblast Culture

72. Layman DL, Mc Goodwin EB, Martin GR. The nature of the collagen synthesized by cultured human fibroblasts. Proc Natl Acad Sci USA 1971; 74: 454-458

73. West MD. The cellular and molecular biology of skin aging. Arch Dermatol 1994; 130: 87-95

74. Moulin V, Castilloux G, Jean A, Garrel DR, Auger FA, Germain L. In vitro models to study wound healing fibroblasts. Burns 1996; 22: 359-362

75. Uitto J, Kouba D. Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci 2000; 24:S60–S69

76. Ghosh AK. Factors Involved in the Regulation of Type I Collagen Gene Expression: Implication in Fibrosis. Exp Biol Med 2002; 227:301–314

77. Kessler-Becker D, Krieg T, Eckes B. Expression of pro-inflammatory markers by human dermal fibroblasts in a three-dimensional culture model is mediated by an autocrine interleukin-1 loop. Biochem J 2004; 379: 351-358.

78. Granstein RD, Flotte TJ, Amento EP. Interferons and collagen production. J Invest Dermatol 1990; 95:75-80

79. Kakehi K, Kinoshita M, Yasueda S. Hyaluronic acid: separation and biological implications. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 797:347-355

80. Warner RL, Bhagavathula N, Nerusu KC, Lateef H, Younkin E, Johnson KJ, Varani J. Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. Exp Mol Pathol 2004; 76:89-95

81. Miura H, Sano S, Higashiyama M, Yoshikawa K, Itami S.Involvement of insulin-like growth factor-I in psoriasis asa paracrine growth factor: dermal fibroblasts play a regulatory role in developing psoriatic lesions. Arch Dermatol Res 2000; 292:590-597

82. Wlaschek M, Ma W, Jansen-Durr P, Scharffetter-Kochanek K. Photoaging as a consequence of natural and therapeutic ultraviolet irradiation-studies on PUVA-induced senescence-like growth arrest of human dermal fibroblasts.Exp Gerontol. 2003; 38:1265-1270

83. Carroll LA, Koch RJ. Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts. Med Sci Monit 2003; 9: 97-108

84. Anderegg U, Prieb J, Hildebrandt G, Saalbach A. Minocycline does not alter collagen type I metabolism of dermal fibroblasts in culture. Arch Dermatol Res 2002; 294:103-108

85. Gendimenico GJ, Mezick JA. Pharmacological effects of retinoids on skin cells. Skin Pharmacol 1993; 6: 24-34

86. Harvey W, Grahame R, Panayi GS. Effects of steriod hormones on human fibroblasts in vitro. II. Antagonism by androgens of cortisol-induced inhibition.Ann Rheum Dis 1976; 35:148-151 87. Carroll LA, Hanasono MM, Mikulec AA, Kita M, Koch RJ. Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts. Dermatol Surg 2002; 28: 704-709.

88. Okano Y, Abe Y, Masaki H, Santhanam U, Ichihashi M, Funasaka Y. Biological effects of glycolic acid on dermal matrix metabolism mediated by dermal fibroblasts and epidermal keratinocytes. Exp Dermatol 2003; 12: 57-63.

89. Krueger GG. Fibroblasts and dermal gene therapy: a minireview. Hum Gene Ther. 2000; 11: 2289-2296.

Dermal Endothelial Cell Culture

90. Davison P, Bensch K, Karasek M. Isolation and long term serial cultivation of endothelial cells from the microvessels of the adult human dermis. In Vitro 1983; 19:937-945

91. Ruszczak Zb, Detmar M, Imke E, Orfanos. Effects of rIFN-alpha,-beta and –gamma on the morphology, proliferation and cell surface antigen expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol 1990; 95: 693-699

92. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4–25

93. Imcke E, Ruszczak Z, Mayer-da Silva A, Detmar M, Orfanos CE. Cultivation of human dermal microvascular endothelial cells in vitro: immunocytochemical and ultrastructural characterization and effect of treatment with three synthetic retinoids. Arch Dermatol Res 1991; 283: 149-157

94. Richard L, Velasco P, Detmar M. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp Cell Res 1998; 240:1-6

95. Pober JS, Kluger MS, Schechner JS. Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann N Y Acad Sci 2001; 941:12-25

96. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000; 5: 40-46

97. Bootle-Wilbraham CA, Tazzyman S, Thompson WD, Stirk CM, Lewis CE. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis 2001; 4:269-275

98. Nor JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 2001; 61: 2183-2188

99. Benndorf R, Boger RH, Ergun S, Steenpass A, Wieland T. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res 2003; 93:438-447

100. Moses AV, Jarvis MA, Raggo C, Bell YC, Ruhl R, Luukkonen BG, Griffith DJ, Wait CL, Druker BJ, Heinrich MC, Nelson JA, Fruh K. A functional genomics approach to Kaposi's sarcoma. Ann NY Acad Sci 2002; 975:180-191

101. Garcia FU, Wojta J, Broadley KN, Davidson JM, Hoover RL: Bartonella bacilliformis stimulates endothelial cells in vitro and is angiogenic in vivo. Am J Pathol 1990; 36:1125-1135

102. Yonekur H, Sakurai S, Liu X, Migita H, Wang H, Yamagishi S-I, Nomura M. Abedin J, Unoki H, Yamamoto Y, Yamamoto H. Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. J Biol Chem 1999; 274:35172-35178

103. Suschek CV, Bruch-Gerharz D, Kleinert H, Forstermann U, Kolb-Bachofen V. Ultraviolet A1 radiation induces nitric oxide synthase-2 expression in human skin endothelial cells in the absence of proinflammatory cytokines. J Invest Dermatol 2001;117: 1200-1205

104. Xiao S, Schmidt RJ, Baylis C. Plasma from ESRD patients inhibits nitric oxide synthase activity in cultured human and bovine endothelial cells. Acta Physiol Scand 2000; 168:175-179

105. Nicosia RF. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis? Am J Pathol 1998; 153: 11-16

106. Yu Y, Moulton KS, Khan MK, Vineberg S, Boye E, Davis VM, O'Donnell PE, Bischoff J, Milstone DS. E-selectin is required for the antiangiogenic activity of endostatin. Proc Natl Acad Sci USA 2004; 101: 8005-8010

107. Asahina A, Tada Y, Nakamura K, Tamaki K. Griseofulvin has a potential to modulate the expression of cell adhesion molecules on leukocytes and vascular endothelial cells. Int Immunopharmacol 2001; 1: 75-83

108. Hettmannsperger U, Tenorio S, Orfanos CE, Detmar M. Corticosteroids induce proliferation but do not influence TNF- or IL-1 beta-induced ICAM-1 expression of human dermal microvascular endothelial cells in vitro. Arch Dermatol Res 1993; 285: 347-351

109. Gille J, Paxton LL, Lawley TJ, Caughman SW, Swerlick RA. Retinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cells. J Clin Invest 1997; 99:492-500

110. Sahota PS, Burn JL, Heaton M, Freedlander E, Suvarna SK, Brown NJ, Mac Neil S. Development of a reconstructed human skin model for angiogenesis. Wound Repair Regen 2003;11: 275-284

Hair Follicle Cell Cultures

111. Harmon CS, Nevins TD, Ducote J, Lutz D. Bisindolylmaleimide protein-kinase-C inhibitors delay the decline in DNA synthesis in mouse hair follicle organ cultures. Skin Pharmacol. 1997; 10: 71-8.

112. Imcke E, Mayer-da-Silva A, Detmar M, Tiel H, Stadler R, Orfanos CE.Growth of human hair follicle keratinocytes in vitro. Ultrastructural features of a new model. J Am Acad Dermatol. 1987; 17 : 779-86.

113. Kiesewetter F, Arai A, Schell H.Sex hormones and antiandrogens influence in vitro growth of dermal papilla cells and outer root sheath keratinocytes of human hair follicles. J Invest Dermatol. 1993; 101: 98-105.

114. Blume U, Schon MP, Zouboulis CC, Detmar M, Orfanos CE. Vellus hair follicle-derived keratinocyte culture: a new experimental model in human hair research. Skin Pharmacol.1994; 7: 27-32.

115. Limat A, French LE, Blal L, Saurat JH, Hunziker T, Salomon D. Organotypic cultures of autologous hair follicle keratinocytes for the treatment of recurrent leg ulcers. J Am Acad Dermatol. 2003; 48: 207-14.

116. Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol. 2001; 36: 29-54.

117. Havlickova B, Biro T, Mescalchin A, Arenberger P, Paus R. Towards optimization of an organotypic assay system that imitates human hair follicle-like epithelial-mesenchymal interactions. Br J Dermatol. 2004 ; 151: 753-65.

118. Jahoda C, Oliver RF. The growth of vibrissa dermal papilla cells in vitro. Br J Dermatol. 1981; 105:623-7.

119. Jahoda CA, Horne KA, Oliver RF. Induction of hair growth by implantation of cultured dermal papilla cells. Nature. 1984; 311: 560-2.

120. Jahoda CA, Reynolds AJ, Oliver RF. Induction of hair growth in ear wounds by cultured dermal papilla cells. J Invest Dermatol. 1993; 101: 584-90.

121. Jahoda CA, Reynolds AJ, Chaponnier C, Forester JC, Gabbiani G.Smooth muscle alpha-actin is a marker for hair follicle dermis in vivo and in vitro. J Cell Sci. 199l; 99:627-36.

122. Almon d-Roesler B, Schon M, Schon MP, Blume-Peytavi U, Sommer C, Loster K, Orfanos CE. Cultured dermal papilla cells of the rat vibrissa follicle. Proliferative activity, adhesion properties and reorganization of the extracellular matrix in vitro. Arch Dermatol Res. 1997; 289:698-704.

123. Almeida Jr. H, Müller F, Zigrino P, Korge B, Krieg T, Mauch C . Expression and activation of matrix metalloproteinases in cultured human dermal papilla cells. Ann Dermatol Venereol 2002; 129:1S515.

124. Thornton MJ, Hibberts NA, Street T, Brinklow BR, Loudon AS, Randall VA.Androgen receptors are only present in mesenchyme-derived dermal papilla cells of red deer (Cervus elaphus) neck follicles when raised androgens induce a mane in the breeding season. J Endocrinol. 2000; 168:401-8.

125. Randall VA, Hibberts NA, Hamada K.A comparison of the culture and growth of dermal papilla cells from hair follicles from non-balding and balding (androgenetic alopecia) scalp. Br J Dermatol. 1996; 134: 437-44.

126. Han JH, Kwon OS, Chung JH, Cho KH, Eun HC, Kim KH. Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle. J Dermatol Sci. 2004; 34:91-8.

127. Tang L, Bernardo O, Bolduc C, Lui H, Madani S, Shapiro J. The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia. J Am Acad Dermatol. 2003; 49:229-33.

Other Cutaneous Cell Culture

128. Fradette J, Larouche D, Fugere C, Guignard R, Beauparlant A, Couture V, Caouette-Laberge L, Roy A, Germain L. Normal human Merkel cells are present in epidermal cell populations isolated and cultured from glabrous and hairy skin sites. J Invest Dermatol. 2003; 120: 313-317.

129. Fukuda J. A pure, monolayer culture of Merkel cells from sinus hair follicles of the rat. Neurosci Lett. 1996; 216:73-76.

130. Krasagakis K, Almond-Roesler B, Geilen C, Fimmel S, Krengel S, Chatzaki E, Gravanis A, Orfanos CE. Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma)in culture and as xenograft. J Cell Physiol. 2001; 187:386-391.

131. Lee CM, Carpenter F, Coaker T, Kealey T. The primary culture of epithelia from the secretory coil and collecting duct of normal human and cystic fibrotic eccrine sweat glands. J Cell Sci 1986; 83:103-18.

132. Uchida N, Oura H, Nakanishi H, Urano Y, Arase S. Dispersed cell culture of human sweat duct cells under serum-free conditions. J Dermatol 1993; 20: 684-690.

133. Schon M, Benwood J, O’Connell-Willstaedt T, Rheainwald JG. Human sweat gland myoepithelial cells express a unique set of cytokeratins and reveal the potential for alternative epithelial and mesenchymal differentation states in culture. J Cell Sci 1999; 112:1925-36.

134. Pedersen PS. Human sweat duct cells in primary culture. Basic bioelectric properties of cultures derived from normals and patients with cystic fibrosis. In Vitro Cell Dev Biol 1989; 25:342-52.

135. Shikiji T, Minami M, Inoue T, Hirose K, Oura H, Arase S. Keratinocytes can differentiate into eccrine sweat ducts in vitro: involvement of epidermal growth factor and fetal bovine serum. J Dermatol Sci. 2003; 33: 141-50.


© 2004 Egyptian Dermatology Online Journal